DJ Crispr Therapeutics Initiated at Outperform by JMP Securities
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
March 04, 2021 08:16 ET (13:16 GMT)
DJ Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
March 04, 2021 08:16 ET (13:16 GMT)